Exact Sciences
EXAS
#1549
Rank
NZ$19.44 B
Marketcap
$105.06
Share price
-0.63%
Change (1 day)
0.99%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -NZ$0.32 Billion

According to Exact Sciences's latest financial reports the company's current earnings are NZ$2.69 Billion. In 2023 the company made an earning of -NZ$0.34 Billion, an increase over its 2022 earnings that were of -NZ$1.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.32 Billion-5.11%
2023 -NZ$0.34 Billion-69.28%
2022 -NZ$1.08 Billion-25.55%
2021 -NZ$1.45 Billion1.68%
2020 -NZ$1.42 Billion271.17%
2019 -NZ$0.39 Billion58.99%
2018 -NZ$0.25 Billion20.89%
2017 -NZ$0.2 Billion-30.95%
2016 -NZ$0.29 Billion5.09%
2015 -NZ$0.28 Billion57.24%
2014 -NZ$0.18 Billion116.53%
2013 -NZ$80.57 Million
2011 -NZ$50.16 Million143.73%
2010 -NZ$20.58 Million27.85%
2009 -NZ$16.1 Million0.27%
2008 -NZ$16.06 Million-20.95%
2007 -NZ$20.31 Million-13.53%
2006 -NZ$23.49 Million-10.07%
2005 -NZ$26.12 Million-21.81%
2004 -NZ$33.41 Million-33.44%
2003 -NZ$50.19 Million-6.51%
2002 -NZ$53.68 Million17.95%
2001 -NZ$45.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.2 Billion-40.71%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.11 B-134.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.22 Million-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$60.85 Million-81.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.89 B-3,966.20%๐Ÿ‡ซ๐Ÿ‡ท France